Ashley F Ward

Years Active: 2020-2020
Publications (10 Years): 3

Foundation Medicine Inc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Foundation Medicine Inc

United States

Senior Director :: Clinical Development

U.S. Food and Drug Administration

United States

Team Leader :: Office of Oncologic Diseases, CDER

Genentech Inc

United States

Associate Director :: Exploratory Clinical Development

University of California San Francisco

United States

Fellow, Faculty Member :: Pediatric Hematology and Oncology

Washington University in Saint Louis School of Medicine

United States

Resident, Chief Resident :: Pediatrics

Publications

Kristen L Mueller, Marc R Theoret, Steven J Lemery, Laleh Amiri-Kordestani, Charlotte E Ariyan, Michael B Atkins, Donald A Berry, Christian U Blank, Angela M DeMichele, Patrick M Forde, Nageatte Ibrahim, Patricia Keegan, Tara C Mitchell, Rebecca A Moss, Caroline Robert, Rajeshwari Sridhara, Janis M Taube, Michael T Tetzlaff, Jennifer A Wargo, Keith T Flaherty, Michael J Kaplan, Suzanne L Topalian, Ashley F Ward, Marc S Hurlbert
Neoadjuvant Therapy for Melanoma: A U.S. Food and Drug Administration-Melanoma Research Alliance Public Workshop. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Kelly J Norsworthy, Flora Mulkey, Emma C Scott, Ashley F Ward, Donna Przepiorka, Rosane Charlab, Sarah E Dorff, Albert Deisseroth, Dickran Kazandjian, Rajeshwari Sridhara, Julia A Beaver, Ann T Farrell, R Angelo de Claro, Richard Pazdur
Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (16) (2020)
Leah A Comment, Ashley F Ward, Alexa B Schrock, David Fabrizio, Jeffrey M Venstrom, Priti S Hegde, Brian M Alexander
Evidence-Based Development and Clinical Use of Precision Oncology Therapeutics. Clinical pharmacology and therapeutics 108 (3) (2020)

Ashley F Ward.css-eqlu8i{font-size:small;padding-left:4px;}